drugset / Trial / NCT00570336
Study of CTS-1027 in Hepatitis C Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine if CTS-1027 can lower elevated liver enzymes in patients with chronic HCV infection.
Timeline
- Start
- 2007-12
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CTS-1027 | Small molecule | 2.5 mg | Oral |
| Subject | CTS-1027 | Small molecule | 5 mg | Oral |
| Subject | CTS-1027 | Small molecule | 10 mg | Oral |
| Subject | CTS-1027 | Small molecule | 30 mg | Oral |